Phibro Animal Health (PAHC) Stock Forecast & Price Target

$21.69 -0.12 (-0.55%)

(As of 12/20/2024 05:16 PM ET)

Phibro Animal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce

Based on 4 Analyst Ratings

Sell
2

Hold
2

Buy
0

Based on 4 Wall Street analysts who have issued ratings for Phibro Animal Health in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 4 analysts, 2 have given a sell rating, and 2 have given a hold rating for PAHC.

Consensus Price Target

$20.50
-5.49% Downside

According to the 4 analysts' twelve-month price targets for Phibro Animal Health, the average price target is $20.50. The highest price target for PAHC is $25.00, while the lowest price target for PAHC is $15.00. The average price target represents a forecasted downside of -5.49% from the current price of $21.69.

Get the Latest News and Ratings for PAHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Phibro Animal Health and its competitors.

PAHC Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	2 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	2 Sell rating(s)	3 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$20.50	$16.50	$15.00	$15.33
Forecasted Upside	-5.49% Downside	-30.56% Downside	-32.68% Downside	36.78% Upside
Consensus Rating	Reduce	Strong Sell	Strong Sell	Hold

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

PAHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PAHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Phibro Animal Health Stock vs. The Competition

Type	Phibro Animal Health	Medical Companies	S&P 500
Consensus Rating Score	1.50	2.81	2.51
Consensus Rating	Reduce	Moderate Buy	Moderate Buy
Predicted Upside	-5.49% Downside	25,828.56% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent PAHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Morgan Stanley 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$20.00 ➝ $25.00	+11.41%
11/12/2024	Barclays 3 of 5 stars		Boost Target	Underweight ➝ Underweight	$13.00 ➝ $20.00	-21.87%
9/10/2024	JPMorgan Chase & Co. 3 of 5 stars		Initiated Coverage	Neutral	$22.00	+7.16%
8/30/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underperform ➝ Underperform	$13.00 ➝ $15.00	-30.14%
12/7/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$9.00	-21.33%
8/29/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$21.00	+40.19%
12/21/2022	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$18.00	+41.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:01 AM ET.

PAHC Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Phibro Animal Health is $20.50, with a high forecast of $25.00 and a low forecast of $15.00.
: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" PAHC shares.
: According to analysts, Phibro Animal Health's stock has a predicted downside of -5.49% based on their 12-month stock forecasts.
: Phibro Animal Health has been rated by research analysts at Barclays, and Morgan Stanley in the past 90 days.
: Analysts like Phibro Animal Health less than other "medical" companies. The consensus rating for Phibro Animal Health is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PAHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

This page (NASDAQ:PAHC) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phibro Animal Health (PAHC) Stock Forecast & Price Target